Friday, April 30, 2010

Should Drug Companies Censor Medical Journals?

›
I have previously addressed the debate over the safety of the diabetes drug Avandia (rosiglitazone) between Steve Nissen, head of cardiology...
2 comments:

What Do Patients Think of Docs' Financial Ties?

›
Adam Licurse, leading a team primarily from Yale, has contributed to our understanding of patient attitudes toward physicians having financi...
1 comment:
Wednesday, April 28, 2010

Federal Settlements: The ACRE Perspective

›
A brief footnote to the previous post on AstraZeneca and Seroquel: As I reported a little while back, I had the pleasure recently of listeni...
3 comments:

The Cost of Doing Business: Same Song, 83rd Verse

›
And today, the drug company settling with the Federal government on criminal charges against off label marketing is: AstraZeneca The drug in...
Tuesday, April 27, 2010

How Good Are Generic Drugs?

›
Thanks to Merrill Goozner for his report and insights: http://www.thefiscaltimes.com/Issues/Health-Care/2010/04/22/Generic-Drugs-on-the-Hot-...
Friday, April 23, 2010

Council of Medical Specialty Societies Code: Strong Enough?

›
The Council of Medical Specialty Societies, of which 32 medical specialty professional organizations are members, has announced a new "...
3 comments:
Tuesday, April 20, 2010

Encounters with Dr. Tom Stossel

›
I spent some of last week at Davidson College in North Carolina, in the company of Dr. Thomas P. Stossel, driving force behind ACRE (Associa...
6 comments: